Search This Blog

Friday, May 3, 2019

Amgen granted orphan status for lung cancer treatment

The FDA granted Amgen orphan status for its treatment of KRAS p.G12C-positive non-small cell lung cancer
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)